Life insurer TAL has formed a specialist board to strengthen its in-house health and medical capabilities.
The Specialist Advisory Board comprises medical experts who advise on cardiology, respiratory conditions, neurology, oncology, endocrinology, psychiatry, neuropsychology and infectious diseases.
TAL Group chief executive and managing director Brett Clark said the independent expert advisory service will share updates on medical advancements and clinical protocols to ensure TAL's approach to product, underwriting and claims reflects the latest medical best practice.
Clark added health and life are intrinsically linked and the Specialist Advisory Board's independent, objective medical expertise gives the confidence TAL is providing customers and partners with the best possible support.
General manager of health services Sally Phillips said the expert panel will provide guidance on new medical treatments, help undertake an annual review of medical definitions and can provide a final expert medical opinion and referral source on individual complex claims cases.
TAL's Specialist Advisory Board Members are: Royal Prince Alfred Hospital cardiologist Ian Wilcox; St Vincent's Clinical School respiratory specialist David Bryant; University of Sydney Chair of Neurology professor, and Brain and Mind Centre co-director Matthew Kiernan; Chris O'Brien Lifehouse chief clinical officer Michael Boyer; and College of Clinical Psychologists fellow George Haralambous.
Latest figures from Strategic Insight show TAL reported strong group insurance inflows in the 12 months to September after winning significant superannuation fund insurance mandates, together with MetLife and AIA Australia.
AIA Australia (28.4%) held the largest market share of the $6.3 billion group insurance market, followed by TAL (26.8%), MetLife (9.9%) and CommInsure (9.8%).
TAL was also among the market leaders in the lump sum category, worth $7.1 billion, behind AMP, MLC Life and ANZ's OnePath.